Live survey304 models · 14 providers · 23,592 auditsAudited implement · SAFE →What changedHow we verifyllms.txt

Agent skill · Audited from source

tooluniverse-crispr-screen-analysis

skill · mims-harvard/tooluniverseApache-2.0 licenceAudited 13 Nov 2026 · source f3e5d653d5f8

★ 1,788pushed 1 day ago
✓SAFEGrade B · 89/100 · 13 Nov 2026 · f3e5d65
1,788repo stars · whole mims-harvard/tooluniverse

Is it safe? Yes — SAFE, grade B (89/100). We read this skill's source at commit f3e5d653d5f8 and found no filesystem, network or shell access and no hard-coded secrets. What it does: Analyze CRISPR-Cas9 genetic screens — MAGeCK gene-level scores, sgRNA count QC, replicate correlation, hit prioritization, and pathway GSEA on screen output. Use for genome-wide essentiality screens, synthetic-lethality…

Ask an AI about this pageGChatGPTCClaudePPerplexityGeGeminiXGrok
More
Cite

Cite this page

ModelsAtlas. “tooluniverse-crispr-screen-analysis (mims-harvard/tooluniverse)”. Retrieved 13 Nov 2026. https://modelsatlas.com/skills/mims-harvard/tooluniverse-crispr-screen-analysis

Trust audit

Audit 0.4.1 · source read 13 Nov 2026

Trust score89/100✓SAFE B
0 critical0 high0 medium2 low0 info

SAFE means nothing in the source contradicts what the skill says it does. Grade B is shared by 17,406 of 18,389 audited skills.

What the source does

  • FilesystemNone observedNo reads or writes in the source
  • NetworkNone observedNo outbound calls in the source
  • ShellNone observedNo commands run in the source
  • DependenciesPinnedNothing floats
  • SecretsNone foundNo keys in source

Five audit layers

LayerWhat we checkResultFindings
L0 ProvenanceRepo owner, licence, archive status, activityPASS0
L1 Static sourceSecrets, path traversal, supply chain, hidden codePASS0
L2 InstructionsPrompt injection, authority framing, hidden directivesPASS2
L3 InventoryThe files and declarations match the sourcePASS0
L4 SandboxRun in isolation and watch behaviourSKIPPED why0

Gates applied: no behavioural pass.

Findings (2)

LOWPrompt injectionprompt.persistence · FALLBACK_PATCH.md:44
F-01 Prompt injectionCWE-94 · CWE-1427Layer L2
### 2. Update PATH 0: Gene Validation (Fallback)
Why
instructs the agent to persist itself in the user's environment
Fix
—
LOWPrompt injectionprompt.persistence · FALLBACK_PATCH.md:138
F-01 Prompt injectionCWE-94 · CWE-1427Layer L2
### 3. Update PATH 1: Essentiality Analysis (Fallback)
Why
instructs the agent to persist itself in the user's environment
Fix
—

Audit 0.4.1 · source sha f3e5d653d5f8 · 13 Nov 2026Report an issue or request a re-scan

Provenance

Who published it, and what the verdict is pinned to

  • Publishermims-harvard GitHub organizationOwner of the repository this skill is read from
  • Source foldermims-harvard/tooluniverse/skills/tooluniverse-crispr-screen-analysisThe exact folder we audited
  • LicenceApache-2.0As the repository states it
  • Commit pinned for this verdictf3e5d653d5f8A new audit runs when the source changes
  • Repository statusNot archivedLast push 1 day ago
  • Sandboxed runNot runSkills are read, not executed; layer L4 is skipped

What it tells the agent

Full source on GitHub ↗

Its description: Analyze CRISPR-Cas9 genetic screens — MAGeCK gene-level scores, sgRNA count QC, replicate correlation, hit prioritization, and pathway GSEA on screen output. Use for genome-wide essentiality screens, synthetic-lethality…

---
name: tooluniverse-crispr-screen-analysis
description: Analyze CRISPR-Cas9 genetic screens — MAGeCK gene-level scores, sgRNA count QC, replicate correlation, hit prioritization, and pathway GSEA on screen output. Use for genome-wide essentiality screens, synthetic-lethality discovery, dropout vs positive-selection screen analysis, target identification, and resistance-screen interpretation. Includes screen-QC and statistical thresholds.
disable-model-invocation: true
---

# ToolUniverse CRISPR Screen Analysis

## RULE ZERO — Check for pre-computed results FIRST

Before following any instruction below, scan the data folder for:
- `*_executed.ipynb` → read with `tu run read_executed_notebook '{"data_folder":"<path>","search":"<keyword>"}'` and cite its cell outputs as the authoritative answer
- Pre-computed result files (CSV/TSV with names like `*results*`, `*deseq*`, `*enrich*`, `*stats*`, `*_simplified.csv`) → read directly and report the requested value
- Canonical analysis scripts (`analysis.R`, `run_*.py`, `find_*.R`, `*.Rmd`) → execute as-is and read the output

Only follow this skill's re-analysis recipe below if **none** of the above exist. Re-running from raw data produces different numbers than the published answer and is much slower (often 5-10× turn count).

---

Comprehensive skill for analyzing CRISPR-Cas9 genetic screens to identify essential genes, synthetic lethal interactions, and therapeutic targets through robust statistical analysis and pathway enrichment.

## Overview

CRISPR screens enable genome-wide functional genomics by systematically perturbing genes and measuring fitness effects. This skill provides an 8-phase workflow for:
- Processing sgRNA count matrices
- Quality control and normalization
- Gene-level essentiality scoring (MAGeCK-like and BAGEL-like approaches)
- Synthetic lethality detection
- Pathway enrichment analysis
- Drug target prioritization with DepMap integration
- Integration with expression and mutation data

---

## Core Workflow

### Phase 1: Data Import & sgRNA Count Processing

Load sgRNA count matrix (MAGeCK format or generic TSV). Expected columns: `sgRNA`, `Gene`, plus sample columns. Create experimental design table linking samples to conditions (baseline/treatment) with replicate assignments.

### Phase 2: Quality Control & Filtering

Assess sgRNA distribution quality:
- **Library sizes** per sample (total reads)
- **Zero-count sgRNAs**: Count across samples
- **Low-count filtering**: Remove sgRNAs below threshold (default: <30 reads in >N-2 samples)
- **Gini coefficient**: Assess distribution skewness per sample
- Report filtering recommendations

### Phase 3: Normalization

Normalize sgRNA counts to account for library size differences:
- **Median ratio** (DESeq2-like): Calculate geometric mean reference, compute size factors as median of ratios
- **Total count** (CPM-like): Divide by library size in millions

Calculate log2 fold changes (LFC) between treatment and control conditions with pseudocount.

### Phase 4: Gene-Level Scoring

Two scoring approaches:
- **MAGeCK-like (RRA)**: Rank all sgRNAs by LFC, compute mean rank per gene. Lower mean rank = more essential. Includes sgRNA count and mean LFC per gene.
- **BAGEL-like (Bayes Factor)**: Use reference essential/non-essential gene sets to estimate LFC distributions. Calculate likelihood ratio (Bayes Factor) for each gene. Higher BF = more likely essential.

### Phase 5: Synthetic Lethality Detection

Compare essentiality scores between wildtype and mutant cell lines:
- Merge gene scores, calculate delta LFC and delta rank
- Filter for genes essential in mutant (LFC < threshold) but not wildtype (LFC > -0.5) with large rank change
- Sort by differential essentiality

Query DepMap/literature for known dependencies using PubMed search.

### Phase 6: Pathway Enrichment Analysis

Submit top essential genes to Enrichr for pathway enrichment:
- KEGG pathways
- GO Biological Process
- Retrieve enriched terms with p-values and gene lists

### Phase 7: Drug Target Prioritization

Composite scoring combining:
- **Essentiality** (50% weight): Normalized mean LFC from CRISPR screen
- **Expression** (30% weight): Log2 fold change from RNA-seq (if available)
- **Druggability** (20% weight): Number of drug interactions from DGIdb

Query DGIdb for each candidate gene to find existing drugs, interaction types, and sources.

### Phase 8: Report Generation

Generate markdown report with:
- Summary statistics (total genes, essential genes, non-essential genes)
- Top 20 essential genes table (rank, gene, mean LFC, sgRNAs, score)
- Pathway enrichment results (top 10 terms per database)
- Drug target candidates (rank, gene, essentiality, expression FC, druggability, priority score)
- Methods section

---

## ToolUniverse Tool Integration

**Key Tools Used**:
- `PubMed_search_articles` - Literature search for gene essentiality and drug resistance
- `ReactomeAnalysis_pathway_enrichment` - Pathway enrichment (param: `identifiers` newline-separated, `page_size`)
- `enrichr_gene_enrichment_analysis` - Enrichr enrichment (param: `gene_list` array, `libs` array)
- `DGIdb_get_drug_gene_interactions` - Drug-gene interactions (param: `genes` as array)
- `DGIdb_get_gene_druggability` - Druggability categories
- `STRING_get_network` - Protein interaction networks
- `kegg_search_pathway` - Pathway search by keyword
- `kegg_get_pathway_info` - Pathway details by ID

**Cancer Context** (essential for drug resistance screens):
- `civic_search_evidence_items` - Clinical evidence for drug resistance/sensitivity
- `COSMIC_get_mutations_by_gene` - Somatic mutation landscape
- `cBioPortal_get_mutations` - Mutations in specific cancer cohorts
- `ChEMBL_search_targets` - Structural druggability assessment

**Expression & Variant Integration**:
- `GEO_search_rnaseq_datasets` / `geo_search_datasets` - Expression datasets
- `ClinVar_search_variants` - Known pathogenic variants
- `gnomad_get_gene_constraints` - Gene constrain

Excerpt, first 6,000 characters of SKILL.md, verbatim from the audited commit. It is text from someone else’s repository, quoted so you can judge it before your agent reads it.

Install

Pinned to the audited commit f3e5d65

Download folder ↗
git clone https://github.com/mims-harvard/tooluniverse
git -C tooluniverse checkout f3e5d653d5f8

The author documents no install command, so this uses the repository directly. Our verdict covers commit f3e5d653d5f8 only.

Works in which agents?

What its own text says, not a test

AgentStatusMore
Claude DesktopMentioned in its text, not testedSkills for Claude Desktop · About Claude Desktop
“Mentioned” means the skill’s text names the agent. We have not run it there.

Audit history

Every audit, every source change

  1. ✓SAFE B 89 / 100

    first audit · source f3e5d653d5f8

README badge

For maintainers · shows the latest audit

ModelsAtlas: SAFE BMODELSATLASSAFE · B
[![ModelsAtlas: SAFE B](https://modelsatlas.com/skills/mims-harvard/tooluniverse-crispr-screen-analysis/badge.svg)](https://modelsatlas.com/skills/mims-harvard/tooluniverse-crispr-screen-analysis/)

The badge shows our verdict and grade for this skill, and links back to this page. It changes when the audit does.

Similar skills

tooluniverse-disease-research✓SAFE

mims-harvard/tooluniverse

Generate comprehensive disease research reports covering genetics (causal genes, GWAS, OMIM), pathways (Reactome, KEGG), drugs (existing therapies, repurposing candidates), clinical trials, epidemiology (prevalence,…

★ 1.8kGrade B
tooluniverse-drug-drug-interaction✓SAFE

mims-harvard/tooluniverse

Assess drug-drug interactions — CYP metabolic interactions (substrate/inhibitor/inducer), transporter (P-gp, BCRP, OATP) effects, pharmacodynamic synergy/antagonism, clinical significance scoring, and management…

★ 1.8kGrade B
tooluniverse-clinical-trial-design✓SAFE

mims-harvard/tooluniverse

Strategic clinical trial design feasibility assessment. Analyzes 6 dimensions (endpoint, population, comparator, effect size, duration, regulatory pathway) using precedent trials and FDA guidance. Produces enrollment…

★ 1.8kGrade B
tooluniverse-clinical-trial-matching✓SAFE

mims-harvard/tooluniverse

AI-driven patient-to-trial matching for precision oncology and rare-disease care. Transforms a patient's molecular profile (mutations, biomarkers, expression) and clinical state into ranked clinical-trial…

★ 1.8kGrade B
tooluniverse-chemical-safety✓SAFE

mims-harvard/tooluniverse

Chemical safety and toxicology assessment integrating ADMET-AI predictions, CTD toxicogenomics, PubChemTox experimental data, GHS/IARC hazard classification, and exposure-context analysis. Use for chemical hazard…

★ 1.8kGrade B
tooluniverse-clinical-guidelines✓SAFE

mims-harvard/tooluniverse

Search and retrieve clinical practice guidelines from 12+ authoritative sources — NICE, WHO, NCCN, AHA, ADA, SIGN, USPSTF, IDSA, NIH consensus, ESMO/ESC/EASL European societies, and US specialty associations. Use for…

★ 1.8kGrade B

Add this badge to your README

[![ModelsAtlas: SAFE B](https://modelsatlas.com/skills/mims-harvard/tooluniverse-crispr-screen-analysis/badge.svg)](https://modelsatlas.com/skills/mims-harvard/tooluniverse-crispr-screen-analysis/)

Questions about tooluniverse-crispr-screen-analysis

What does the tooluniverse-crispr-screen-analysis skill do?
Democratizing AI scientists with ToolUniverse
Is tooluniverse-crispr-screen-analysis safe to install?
The audit found nothing in the source that contradicts what it says it does, and graded it B (89/100). Grade A is held back for packages that have also passed a sandboxed behavioural run, which is why a clean skill reads B.
What can tooluniverse-crispr-screen-analysis access on my machine?
The audit observed no filesystem, network or shell use at all in its source.
Which assistants does tooluniverse-crispr-screen-analysis work with?
Its documentation mentions claude-desktop. That is what the text claims, not a compatibility test we ran.
How current is this page?
The grade is for one exact copy of the source (f3e5d653d5f8), read on 2026-11-13. The repository is watched, and a new audit runs when it changes — this is the first audit.

Sources

Spotted something wrong? Report a correction · Methodology

Keep going in your AI

Opens with this page as the source. We add nothing else to the prompt.